ProQuad
NDC 0006-4171, Measles, Mumps, Rubella and Varicella Virus Vaccine Live, injection, powder, lyophilized, for suspension, from Merck Sharp & Dohme LLC.
- Product NDC
- 0006-4171
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAMUSCULAR, SUBCUTANEOUS
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125108
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN1000 [TCID_50]/.5mL
- MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN20000 [TCID_50]/.5mL
- RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN1000 [TCID_50]/.5mL
- VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN9772 [PFU]/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Chickenpox Vaccine [CS]; Herpes Zoster Vaccine [CS]; Live Attenuated Herpes Zoster Virus Vaccine [EPC]; Live Attenuated Measles Virus Vaccine [EPC]; Live Attenuated Mumps Virus Vaccine [EPC]; Live Attenuated Rubella Virus Vaccine [EPC]; Live Attenuated Varicella Zoster Virus Vaccine [EPC]; Measles Vaccine [CS]; Mumps Vaccine [CS]; Rubella Vaccine [CS]; Vaccines, Attenuated [CS]; Vaccines, Attenuated [CS]; Vaccines, Attenuated [CS]; Vaccines, Attenuated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0006-4171-00 | 00006417100 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4171-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4171-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0006-4171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0006-4171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.